Meanwhile, TP53 mutations can also regulate CD4+ T cells recruitment and their immune activity, thus leading to tumor cells escape from immune surveillance and promoting the tumor progression (Wellenstein et al., 2019). This evidence concerns the gene TP53 and neoplasm.